X
    學術可視化工作室RC   登錄   提交文稿
學術英文編修

EXPERT OPINION ON EMERGING DRUGS

期刊標題檢索 EXPERT OPIN EME 最新評論: The review process may take a while and has not been completed yet (2021-12-30)


期刊名稱:   ISSN:   主題領域:   影響因子範圍: -
索引:   類別:   開放訪問:   排序方式:

[EXPERT OPINION ON EMERGING DRUGS]您好,您是該頁面的第 8978 位訪客。

期刊簡介
期刊名稱EXPERT OPINION ON EMERGING DRUGS EXPERT OPINION ON EMERGING DRUGS
LetPub Score
6.2
50 ratings
Rate

Reputation
7.6

Influence
4.9

Speed
7.0

期刊簡稱EXPERT OPIN EMERG DR
ISSN1472-8214
E-ISSN1744-7623
h-index43
CiteScore
CiteScoreSJRSNIPCiteScore Rank
5.900.8810.727
Subject fieldQuartilesRankPercentile
Category: Medicine
Subcategory: Pharmacology (medical)
Q280 / 272
Category: Medicine
Subcategory: Pharmacology
Q2125 / 313

自引率 (2023-2024)0.00%自引率趨勢
掲載範囲
Expert Opinion on Emerging Drugs (ISSN 1472-8214 [print], 1744-7623 [electronic]) is a MEDLINE-indexed, peer-reviewed, international journal publishing structured reviews on Phase II and Phase III drugs/drug classes emerging onto the market across all therapy areas, providing expert opinion on their potential impact on the current management of specific diseases.
官方網站http://www.tandfonline.com/loi/iemd20
在線稿件提交
開放訪問No
出版商Taylor and Francis Ltd.
主題領域医学
出版國/地區ENGLAND
發行頻率四半期刊行
創刊年2001
每年文章數24每年文章數趨勢
黃金OA百分比6.98%
Web of Science 四分位
2023-2024
WOS Quartile: Q2

CategoryEditionJIF QuartileJIF RankingJIF Percentage
PHARMACOLOGY & PHARMACYSCIEQ2167/354
索引 (SCI or SCIE)Science Citation Index Expanded
鏈接到PubMed Central (PMC)https://www.ncbi.nlm.nih.gov/nlmcatalog?term=1472-8214%5BISSN%5D
平均審稿時間 *來自出版商的數據:
來自作者的數據: >12 Week(s), or Invited contributions
競爭力 *來自作者的數據: Moderate
參考鏈接
相關期刊 【EXPERT OPINION ON EMERGING DRUGS】CiteScore趨勢
自引率趨勢 每年文章數趨勢
作者評論
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。
  • 同一學科的期刊
  • CiteScore趨勢
  • 自引率趨勢
  • 每年文章數趨勢
  •  
    學科內的可信期刊 影響因子
    PHARMACOLOGICAL REVIEWSH-index: 210

    CiteScore: 34.70
    DRUG RESISTANCE UPDATESH-index: 100

    CiteScore: 26.20
    ADVANCED DRUG DELIVERY REVIEWSH-index: 278

    CiteScore: 28.10
    TRENDS IN PHARMACOLOGICAL SCIENCESH-index: 201

    CiteScore: 23.90
    PHARMACOLOGY & THERAPEUTICSH-index: 180

    CiteScore: 23.00
    MEDICINAL RESEARCH REVIEWSH-index: 119

    CiteScore: 29.30
    PHARMACOLOGICAL RESEARCHH-index: 118

    CiteScore: 18.70
    ARCHIVES OF PHARMACAL RESEARCHH-index: 75

    CiteScore: 13.40
    BIOMEDICINE & PHARMACOTHERAPYH-index: 78

    CiteScore: 11.90
    BRITISH JOURNAL OF PHARMACOLOGYH-index: 190

    CiteScore: 15.40
    學科內最受檢索的期刊 頁面查看次數
    BIOMEDICINE & PHARMACOTHERAPY498579
    PHYTOMEDICINE343291
    LIFE SCIENCES288962
    PHARMACOLOGICAL RESEARCH243027
    International Journal of Pharmaceutics242636
    European Journal of Pharmacology204466
    BIOCHEMICAL PHARMACOLOGY202912
    JOURNAL OF NATURAL PRODUCTS196809
    BRITISH JOURNAL OF PHARMACOLOGY165359
    MOLECULAR PHARMACEUTICS162930
  •  

    EXPERT OPINION ON EMERGING DRUGS EXPERT OPINION ON EMERGING DRUGS
    明年預測:
    穩步上升 無變化 逐步下降  刷新
  •  

     
  •  

     


首頁    上一頁    1    下一頁    末頁  (頁
/1)
  [EXPERT OPINION ON EMERGING DRUGS] 的評論撰寫評論
作者: 维尔娜菲茨杰拉德


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-30 23:57:40 評論於
The review process may take a while and has not been completed yet
(0) 讚! | 维尔娜菲茨杰拉德

作者: 维尔娜菲茨杰拉德


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-30 21:52:27 評論於
Submission complete - Formatting review - Editor initial review - Peer review - Review completed - Editor final review - Author revision
(0) 讚! | 维尔娜菲茨杰拉德

作者: 八坂篷蔚


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-27 21:57:01 評論於
What is the process for peer review?
(0) 讚! | 八坂篷蔚

作者: Darlene Pepys


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-27 12:08:23 評論於
Why haven't I heard back after a month of applying?
(0) 讚! | Darlene Pepys

作者: 凌霄高洁


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2017-07-18 19:10:14 評論於
3-point margin, hoping to remain stable, a slight increase would be nice
(0) 讚! | 凌霄高洁

作者: 凌霄高洁


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2011-06-29 20:06:30 評論於
Bullish, if it goes up a little more tomorrow, it may break 3 points
(0) 讚! | 凌霄高洁

首頁    上一頁    1    下一頁    末頁  (頁
/1)

開始撰寫 [EXPERT OPINION ON EMERGING DRUGS] 的評論:





Contact us

Contact us  

Your name*

Your email*

Your message*

Please fill in all fields and provide a valid email.

Security Code*